CRISPR Therapeutics AG
2021 Q4 - 2025 Q4 (12 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/15/2026 | 286 | 0.0% | 5,327 | 12/31/2025 |
| 2024 Q2 | 7/26/2024 | 1,704 | 0.0% | 31,550 | 6/30/2024 |
| 2024 Q1 | 4/29/2024 | 5,379 | 0.0% | 78,924 | 3/31/2024 |
| 2023 Q4 | 1/25/2024 | 2,318 | 0.0% | 37,021 | 12/31/2023 |
| 2023 Q3 | 10/27/2023 | 13,045 | 0.0% | 287,394 | 9/30/2023 |
| 2023 Q2 | 7/18/2023 | 18,341 | 0.0% | 326,698 | 6/30/2023 |
| 2023 Q1 | 4/13/2023 | 13,969 | 0.0% | 308,834 | 3/31/2023 |
| 2022 Q4 | 1/23/2023 | 10,563 | 0.0% | 259,862 | 12/31/2022 |
| 2022 Q3 | 10/26/2022 | 17,577 | 0.0% | 268,992 | 9/30/2022 |
| 2022 Q2 | 7/25/2022 | 16,636 | 0.0% | 273,783 | 6/30/2022 |
| 2022 Q1 | 5/2/2022 | 34,621 | 0.0% | 551,564 | 3/31/2022 |
| 2021 Q4 | 1/28/2022 | 21,717 | 0.0% | 286,595 | 12/31/2021 |